Talzenna 1 mg, Hartkapseln

7680671410068 CH-67141 Kapseln

Associated product:

TALZENNA caps 1 mg bte 30 pce
Talzenna 1 mg, Hartkapseln
Talzenna 1 mg, Hartkapseln
Talzenna 1 mg, Hartkapseln
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
15/10/2025
Summary of Product Characteristics
Français
15/10/2025
Summary of Product Characteristics
Italien
15/10/2025
Patient information leaflet
Allemand
29/08/2024
Patient information leaflet
Français
29/08/2024
Patient information leaflet
Italien
29/08/2024

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 5100.75
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2020

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
67141
Drug name
Talzenna, Hartkapseln
Galenic form
KAPS
ATC Code
L01XK04
Authorization status
Z
Dispensing category
A
First authorization
12/12/2019
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Lokal fortgeschrittenes oder metastasiertes HER2-negatives Mammakarzinom mit einer Keimbahn-BRCA-Mutation, nach einer Anthracyclin- und/oder einer Taxan-Behandlung entweder in neoadjuvanter, adjuvanter oder lokal fortgeschrittener/metastasierter Situation; in Kombination mit Enzalutamid: metastasiertes, kastrationsresistentes Prostatakarzinom mit Mutationen in homologen Rekombinationsreparaturgenen ([HRR] Gen-mutiert), wenn eine Chemotherapie klinisch nicht indiziert ist.

Package details

Description (FR)
TALZENNA caps 1 mg bte 30 pce
Description (DE)
TALZENNA Kaps 1 mg Ds 30 Stk
Market launch
12/12/2019
Narcotic (BTM)
No

Other package sizes (4)

TALZENNA caps 0.25 mg bte 30 pce
30 KAP
GTIN: 7680671410020
View
TALZENNA caps 0.1 mg bte 30 pce
30 KAP
GTIN: 7680671410075
View
TALZENNA caps 0.35 mg bte 30 pce
30 KAP
GTIN: 7680671410082
View
TALZENNA caps 0.5 mg bte 30 pce
30 KAP
GTIN: 7680671410099
View